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There is a close correlation between endothelin-1 (ET-1) and microRNA-1 (miRNA-1) expression in
the heart, but whether ET-1 expression is regulated by miRNA-1 warrants further research. Our
results revealed multiple clues suggesting that miRNA-1 may participate in inhibiting ET-1 gene
expression. The inhibitory effect of miRNA-1 on recombinant luciferase reporter gene was mediated
by the target sequence at the 127th nucleotide on ET-1 30UTR. We further conﬁrmed that miRNA-1
could inhibit endogenous ET-1 gene expression at the post-transcriptional level. Our study provides
a new perspective on the regulatory mechanism of ET-1 gene.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Endothelin-1 (ET-1) was ﬁrst discovered, isolated and puriﬁed
from porcine aortic endothelial cell cultures by Yanagisawa et al.
in 1988 [1]. ET-1 is a cardiovascular active polypeptide containing
21 amino acids, and mainly distributes in the cardiovascular sys-
tem [1]. ET-1 participates in a series of physiologic and pathologic
processes including heart development, myocardial hypertrophy
and arrhythmia [2–4]. ET-1 gene is regulated by different levels
of expression, and regulation at the post-transcriptional level is
of great signiﬁcance to ET-1 gene expression. 30 Untranslated
region (30UTR) of ET-1 mRNA has several AU-rich response ele-
ments, which directly affect mRNA stability [5]. Our previous study
in an acute ischemic arrhythmia rat model had demonstrated that
both ET-1 mRNA antisense oligonucleotide and ET-1 10–23 deoxy-
ribozyme could down-regulate ET-1 gene expression effectively
and reduce occurrences of acute ischemic arrhythmia [6,7], indi-
cating that both endogenous regulatory mechanism and exogenous
intervention could affect ET-1 gene expression at the post-tran-
scriptional level.chemical Societies. Published by E
f Physiology and Neurobiol-
inchuan, China (Y. Wen-Jun),
ical University, 800 Xiangyin
Yuan), renanjing@gmail.comMicroRNAs (miRNAs) are endogenous single-stranded small
molecular RNA discovered in organisms in recent years, with 19–
22 nucleotides in length and highly conserved sequences between
the species [8]. miRNAs inhibit mRNA translation or induce mRNA
degradation by incomplete or complete compensatory binding be-
tween corresponding target sequence bases on target gene mRNA
30UTR, and further silence the target gene at the post-transcrip-
tional level [9,10]. More than 600 miRNAs have been discovered
in organisms, and some miRNAs such as miRNA-1, speciﬁcally
and highly expressed in cardiac tissues, participated in various
physiologic and pathologic processes including heart development
[11], myocardial hypertrophy [12] and arrhythmia [13].
Multiple studies [14,15] demonstrated that miRNA-1 expression
increased gradually during differentiation of cardiac and skeletal
muscle cells, while Juan et al. reported that the ET-1 protein content
in the cell supernatant decreased signiﬁcantly before and after dif-
ferentiation ofDMSO-inducedP19 teratoma cells to cardiomyocytes
[16]. Some more recent studies [12,13,17] showed that miRNA-1
expressiondecreasedmarkedly in theprocess of cardiac and skeletal
muscle hypertrophy. Over-expression of miRNA-1 may inhibit car-
diac muscle hypertrophy induced by ET-1, and the expression of
endogenous ET-1was increasedmarkedly in cardiomyocytes during
the process of cardiacmuscle hypertrophy. This negative correlation
in expression and functional effect during heart development and
pathologic processes betweenmiRNA-1 andET-1 suggests thatmiR-
NA-1 may inhibit ET-1 gene expression. Therefore, whether ET-1
expression is regulated by miRNA-1 warrants further study.lsevier B.V. All rights reserved.
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2.1. Cell culture and transfection
Hela and 293T cells were cultured in DMEM containing 10%
fetal bovine serum (FBS, Biosource) and 100 U/ml penicillin/strep-
tomycin (Gibco). When cells grew to 80–90% of the 10 cm plate,
they were digested with 0.25% trypsin-EDTA (Gibco), seeded to
24-well plates, cultured in a 37 C 5% CO2 incubator, and transfec-
ted with plasmid vectors using lipofectamine 2000 (Invitrogen) in
the following day.
293T transfection: 293T cells were seeded to a 24-well plate at
2  105/L and co-transfected by 2 lg/well of miRNA-1 pSuper,
miRNA-126 pSuper and pSuper together with ET1-30UTR-PGL3
recombinant luciferase reporter plasmid (100 ng/well) with differ-
ent lengths of ET1-30UTR segments and Renilla luciferase reporter
gene (5 ng/well). Luciferase expression was detected 24 h after
transfection on a Chemiluminescence detector using dual lucifer-
ase reporter gene system (Promega), and was normalized by Renil-
la luciferase. Hela transfection: Hela cells were seeded to a 24-well
plate at 3  105/L for 24 h, and then transfected with miRNA-1
pSuper, miRNA-126 pSuper, miRNA-133 pSuper and pSuper empty
vector (2 lg/well) using liposomes. Cells were cultured at 37 C,
and the medium was refreshed 8 h after transfection. The superna-
tant was discarded 24 h after transfection. The wells were washed
with PBS. The medium was changed to colorless serum-free DMEM
medium (300 ll/well). The supernatant was harvested and de-
tected using as human ET-1 ELISA kit. Cells were lysed with RIPA
cell lysate and the lysate was collected for total protein quantiﬁca-
tion and ELISA normalization.
2.2. Culture and differentiation of mouse C2C12 myoblasts
Mouse C2C12 cells were cultured in DMEM containing 10% FBS
and 100 U/ml penicillin/streptomycin. When cells grew to 70–80%
of the 10 cm plate, they were digested with 0.25% trypsin-EDTA,
seeded to 24-well plates, and cultured in a 37 C 5% CO2 incubator.
The following morning, the medium was changed to DMEM con-
taining 2% heat-inactivated horse serum to induce cell differentia-
tion. Samples were collected at day 1, 4 and 6 to extract total RNA
for analysis of changes in miRNA-1 and ET-1 mRNA expressions.
2.3. SYBR Green quantitative PCR assays for mature miRNA and ET-1
gene expression
Using total RNA of mouse and human tissue cells as the tem-
plate, and miRNA speciﬁc stem-loom structured reverse transcrip-
tion (RT) primer, random primer and OligodT20 as RT primers,
cDNA templates of miRNA, U6 spliceosomal RNA and ET-1 mRNA
were obtained. Using SYBR Premix Ex Taq (TakaRa) and speciﬁc
quantitative PCR primers, relative expressions of miRNA, U6 and
ET-1 mRNA in the templates were detected. U6 is spliceosome
RNA, the abundance of which is similar to small molecular RNA,
and used as miRNA internal reference. PBGD (porphobilinogen
deaminase) is a house-keeping gene, and used as a common gene
as internal reference of Myogenin, Pola and ET-1. Each experiment
was repeated for at least three times.
2.4. Bioinformatics prediction
Using TargetScan and BiBiserve miRNA target gene prediction
software, prediction analysis of miRNA-1 target sequences on
ET-1 30UTR was performed.
2.5. Vector construction and reporter gene assays
Using cDNA of endothelial cells from the human umbilical vein
as the template, PCR ampliﬁed ET-1 30UTR sequences with differentlengths were subcloned to pGL3 plasmid (Promega) luciferase
reporter gene downstream to construct a recombinant luciferase
reporter gene pGL3 vector expressing the integrated ET-1 30UTR.
Using Hela genome DNA as the template, miRNA precursor se-
quences were ampliﬁed and subcloned to polyclonal sites in the
pSuper plasmid H1 RNA promoter downstream to construct re-
combinant pSuper plasmids expressing miRNA precursors. The
above two recombinant vectors were co-transfected with 293T
cells for 24 h, and then lysed with lysate. The amount of luciferase
relative expression in the samples was detected using the dual
luciferase reporter gene assay kit (Promega). The experiment was
repeated more than three times. The sequences and lengths of
ET-1 30UTR primers, and subcloning strategy are described in
details in Supplementary data.
2.6. miRNA target sequence mutagenesis
Using recombinant pGL3 plasmids integratedwithwild-type ET-
1 30UTR as the template, and primers at themutated target sites and
high-ﬁdelity enzyme (TaKaRa) PCR, linear products of mutated tar-
get sequences were obtained. After digesting the plasmid template
in PCR products by DpNI (Fermentas), the linear products were
reconstructed in Escherichia coli DH5a to obtain target sequence-
mutated cyclinized pGL3 plasmids. Mutagenesis of the target se-
quence was identiﬁed by sequencing. See details in Supplementary
data.
2.7. Enzyme-linked immunosorbent assay (ELISA)
Themediumwas changed to serum-freeDMEM24 haftermiRNA
transfection. After additional 24 h culture, the relative ET-1 content
in the supernatant of each group was detected with a human ET-1
ELISA assay kit (R&D), and standardized to total cellular protein.
2.8. Statistical analysis
Quantitative data were expressed as mean ± SD. Differences
between groups were determined with a one-way ANOVA fol-
lowed by a Student–Newman–Keuls test. A value of P < 0.05 was
considered to denote statistical signiﬁcance.
3. Results
3.1. miRNA-1 and ET-1 mRNA expression distribution and correlation
in mouse and human tissue cells
Of the mouse heart, liver, spleen, lung, kidney, brain, skeletal
muscle and gastrointestinal smooth muscle, miRNA-1 was speciﬁ-
cally and highly expressed in heart and skeletal muscle tissues,
while the expression level of miRNA-1 was relatively low in the
other mouse tissues and organs (Fig. 1A). ET-1 mRNA expression
was mainly expressed in the lung, kidney and stomach intestine,
and very low in the skeletal muscle and liver (Fig. 1B). miRNA-1
expressionwas speciﬁcally andhighly expressed in the humanheart
and skeletalmuscle tissues, and low inHela, 293Tandhumanumbil-
ical vein endothelial cells (HUVEC) (Fig. 1C). ET-1 mRNA expression
was the highest in endothelial cells; relatively low in Hela cells and
heart tissue; and very low in the skeletal muscle and 293T cells
(Fig. 1D). An overview of the above results showed that there was
a negative correlation in distribution of miRNA-1 and ET-1 mRNA
expressions, suggesting that ET-1 may be the target gene of miRNA.
3.2. Change and correlation of miRNA-1 and ET-1 mRNA expressions
during differentiation of mouse C2C12 myoblasts
To further clarify the clue of ET-1 as miRNA-1 target gene,
changes in miRNA-1 and ET-1 mRNA expressions during
Fig. 1. Relative miRNA-1 (miR-1) and ET-1 mRNA levels detected by Real-time PCR in different mouse tissues (A, B), human tissues and cell lines (C, D). (A) miR-1 was highly
expressed in mouse heart and skeletal muscle tissues. (B) ET-1 mRNA expression was mainly expressed in the mouse lung, kidney and stomach intestine. (C) miR-1 was
highly expressed in the human heart and skeletal muscle tissues. (D) ET-1 mRNA was highly expressed in HUVEC.
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the previous study [18], expression of myogenin mRNA (a marker
for myogenic differentiation) and miRNA-1 increased gradually
with C2C12 differentiation (Fig. 2A and B). In the present study,
we found expression of ET-1 mRNA and miRNA-1 target gene DNA
polymerase a-subunit (pola) decreased gradually with C2C12 dif-
ferentiation (Fig. 2B and C), suggesting that miRNA-1 may inhibit
ET-1 gene expression during differentiation of muscle cells.
3.3. Bioinformatics prediction of miRNA-1 target sequences on ET-1
30UTR
Usingmultiple bioinformatics prediction websites and software,
we discovered three potential miRNA-1 target sequences on ET-1
30UTR. They originated from the 127th, 367th and 539th nucleotide
on ET-1 30UTR respectively. Subsequently, we analyzed compensa-
tory pairing of the three target sequences with miRNA-1, and the
conservative properties and other bioinformatic parameters of the
RNA double-strand structures, free energy and target sequences
formed from their combination. The left half diagraph of Fig. 3A–
C shows complementary base pairing of miRNA-1 and ET-1 30UTR,
where 7 nucleotides at 2–8 sites from miRNA 50 end are continu-
ously and complementarily paired with the predicted target se-
quence of ET-1 30UTR, which is critical for both of them and this
sequence is also called the seed sequence [19]. The right half dia-
graph of Fig. 3A–C shows the double-stranded RNA secondary
structure after their combination. The lower Mfe is the free energy
of the secondary structure. The lower the free energy, the more
stable their combination will be and the more likely they will com-
bine. It was found: (1) The sequence at the 127th site was continu-
ously paired with miRNA seed sequence without G:U pairing; RNAdouble-stranded free energy was the lowest in the three target se-
quences (18.7 kcal/mol), and the double-stranded structure was
the most stable; the seed sequence pairing region was completely
conserved between the species, and itmay be a functional target se-
quence (Fig. 3A). (2) There was a G:U pair in the continuous pairing
region of the 367th target sequence and miRNA seed sequence,
where RNA double-stranded free energy was slightly higher than
that at the 127th target sequence (15.4 kcal/mol); the seed se-
quence pairing region was completely conserved, and the target
sequence pairing region beyond the seed sequence was also highly
conserved, and may be a functional target sequence (Fig. 3B). (3)
There were three groups of G:U pairs in the continuous pairing re-
gion of the 539th target sequence and miRNA seed sequence. RNA
double-stranded free energy was the highest in the three target se-
quences (13.0 kcal/mol), and the secondary structure was the
most unstable; the seed target pairing region was not completely
conserved between the species; the possibility of being miRNA-1
functional target sequence was the lowest (Fig. 3C). Predicted
miRNA-1 binding site in ET-1 30-UTR is highly conserved in the se-
quences within homo sapiens, mus musculus, rattus norvegicus,
and canine familiaris (Fig. 3D).
3.4. miRNA-1 inhibits the expression of ET-1 30UTR-integrated
luciferase reporter gene
The luciferase reporter gene system is the most common tech-
nique used for studying the role of miRNA in target gene function-
ing. In the present study, we ﬁrst constructed a miRNA expression
vector and a recombinant pGL3 vector integrated with ET-1 30UTR
to co-express corresponding miRNA and recombinant luciferase in
293T cells. It was found that the expression level of recombinant
Fig. 2. Relative levels of myogenin mRNA, miR-1, ET-1 mRNA and pola mRNA at different stages during C2C12 differentiation. (A) Myogenin mRNA increased gradually with
C2C12 differentiation. (B) miR-1 increased, but ET-1 mRNA decreased gradually with C2C12 differentiation. (C) Pola mRNA decreased gradually with C2C12 differentiation.
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group was signiﬁcantly lower than that in pSuper (P < 0.05)
(Fig. 4). There was no signiﬁcant difference between miRNA-126
pSuper or miRNA-133 pSuper and pSuper group. The miRNA-1
transfected vector showed no signiﬁcant inhibitory effect on the
recombinant luciferase reporter gene and luciferase reporter gene
with reversely integrated (30–50) ET-1 30UTR (Fig. 4).
Knowing that there were three miRNA target sequences on ET-1
30UTR as detected by bioinformatics prediction, we deleted and
mutated these sequences to further conﬁrm the target sequence
mediating the miRNA-1 function. Fig. 5A shows the construction
of the recombinant pGL vector with the miRNA-1 target sequence
deleted and mutated. Fig. 5B is the design protocol of miRNA-1 tar-
get gene mutagenesis at the 127th nucleotide on ET-1 30UTR. The
result of luciferase reporter gene assay showed that miRNA-1was
able to inhibit the protein expression of reporter gene integrated
with ET-1 30UTR (1-1102)-Wt in the full-length sequence (includ-
ing the 127th, 367th and 539th target sequence) (P < 0.05)
(Fig. 5C), indicating that miRNA-1 was functional to ET-1 30UTR.
miRNA-1 was able to inhibit the protein expression of reporter
gene integrated with ET-1 30UTR (1-404)-Wt segments (only
including segments at the 127th and 367th predicted target se-
quence) (P < 0.05), suggesting that both 127th and 367th sites
could mediate the inhibitory effect of miRNA-1. miRNA-1 showed
no signiﬁcant inhibitory effect on luciferase reporter gene inte-
grated with ET-1 30UTR (155-1102)-Wt (only including the pre-
dicted target sequence at the 367th and 539th sites), suggestingthat the predicted target sequence at the 367th and 539th sites
did not participate in mediating the inhibitory effect of miRNA-1,
and the actual functional sequence may be at the 127th site.
miRNA-1 showed no signiﬁcant inhibitory effect on the protein
expression of luciferase reporter gene integrated with ET-1 30UTR
(1-404)-Mut (only including the predicted target sequence at the
127th and 367th sites, of which the 127th target sequence was
mutated), indicating that the predicted target sequence at the
127th site was the functional target sequence that mediated the
inhibitory effect of miRNA-1 (Fig. 5C). miRNA-1 showed no signif-
icant inhibitory effect on the protein expression of luciferase repor-
ter gene integrated with ET-1 30UTR (1-404)-Mut (only including
the predicted target sequence at the 127th and 367th sites, of
which the 127th target sequence was mutated), indicating that
the predicted target sequence at the 127th site was the functional
target sequence that mediated the inhibitory effect of miRNA-1
(Fig. 5C).
3.5. miRNA-1 inhibits endogenous ET-1 expression in Hela cells
Hela cells can express and secrete a certain amount of endoge-
nous ET-1. Knowing that miRNA-1 was functional to ET-1 30UTR,
we used the Hela cell model to further investigate the regulatory
effect of miRNA-1 on endogenous ET-1 expression. It was found
that miRNA-1 expression in the miRNA-1 pSuper (miRNA-1expres-
sion vector) group was signiﬁcantly higher than that in the other
groups (Fig. 6A), indicating that plasmids could speciﬁcally and
Fig. 3. Prediction for miR-1 potential target in 30UTR of ET-1 mRNA. (A–C) Duplexes and their secondary structures of the target sites in ET-1 30-UTR with miR-1. In the RNA
duplexes, the target site in ET-1 30-UTR (red strand) is drawn in a 50–30 orientation (left to right) and the miRNA (green strand) is drawn in a 30–50 orientation (left to right). (D)
Conservation of predicted miR-1 binding site in ET-1 30-UTR between different species. Outlined boxes demark the region that is perfectly complimentary to miR-1 and is
most important for miRNA–mRNA interaction.
Fig. 4. miR-1 represses expression of luciferase reporter gene fused with forward
ET-1 30UTR. Expression level of recombinant luciferase reporter gene in miR-1
transfected pSuper plasmid group was signiﬁcantly lower than that in pSuper.
⁄P < 0.05 compared with pSuper group.
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of miRNA on post-transcription level of the target gene can be
achieved by two approaches: inhibiting translation of the target
gene or degrading mRNA of the target gene [8], we further detected
the mRNA and protein levels of ET-1. The relative content of ET-1
protein in the supernatant of miRNA-1 pSuper transfected group
was 0.76 ± 0.02, and it was signiﬁcantly lower than that in pSuper,
miRNA-126 pSupe (1.16 ± 0.14) or miRNA-133 pSuper (1.04 ± 0.14)
transfected group (P < 0.05) (Fig. 6B). However, there was no signif-
icant difference in ET-1 mRNA expression between the groups
(Fig. 6C), indicating that miRNA-1 regulates ET-1 expression by
inhibiting the translation process of ET-1 mRNA, but not by
degrading ET-1 mRNA after transcription.4. Discussion
In the present study, we analyzed the distribution and change of
miRNA-1and ET-1 mRNA expression in mouse and part of human
tissue cells and during differentiation of mouse C2C12 myoblasts.
It was found that there was a negative correlation between the dis-
tribution and change of miRNA-1 and ET-1 mRNA expression.
Searching of the bioinformatics information revealed three poten-
tial miRNA-1 functional target sequences on ET-1 30UTR. Analysis
Fig. 5. miR-1 inhibits the expression of ET-1 30UTR-integrated luciferase reporter
gene. (A) Sketch diagram of target deletion and mutation of ET-1 30UTR fused into
pGL3. (B) Design of 127th target mutation. (C) Relative expression levels of
luciferase reporter genes fused with ET-1 30UTRs in response to miRNAs. 30UTR (1-
1102)-WT: ET-1 30UTR full-length segment (wild type). 30UTR (1-404)-WT: ET-1
30UTR partial segment (nucleotide sequence fragment from 1–404 sites of 30UTR,
with the 3rd target site deleted). 30UTR(155-1102)-WT: ET-1 30UTR partial segment
(nucleotide sequence fragment from 155–1102 sites of 30UTR, with the 1st target
site deleted). 30UTR(1-404)-Mut: ET-1 30UTR partial segment (mutation type)
(mutation type of the 1st prediction target site of 30UTR (1-404)-WT miR-1). 30UTR
(1-1102)-Ivert: ET-1 30UTR WT full-length segment was oppositely inserted into
pGL3 recombinant plasmid. Both miR-126 pSuper and pSuper plasmids are served
as controls. ⁄P < 0.05 compared with pSuper group. Fig. 6. (A) Efﬁciency and speciﬁcity of miR-1 pSuper for miR-1 expression in Hela in
response to miRNAs transfection. (B) Relative protein levels of ET-1 in supernatant
of Hela transfected with pSuper and recombined miRNA expression vector. (C) ET-1
mRNA levels in Hela transfected with pSuper and recombined miRNA expression
vectors. ⁄P < 0.05 compared with pSuper group.
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inhibit the expression of luciferase reporter gene integrated with
ET-1 30UTR. Using the method of target sequence deletion and
mutagenesis, we conﬁrmed that the inhibitory effect of miRNA-1
on recombinant luciferase reporter gene was mediated through
the target sequence of the 127th nucleotide on ET-1 30UTR. Finally,
we demonstrated in a Hela cell model that miRNA-1 could inhibit
the expression of endogenous ET-1 gene at the post-transcriptional
level. The results of our study conﬁrmed thatmiRNA-1had an inhib-
itory effect on the expression of ET-1 gene, and that this inhibitory
effect occurred at the post-transcriptional level, thus clarifying the
target sequence that mediates the inhibitory effect, and widening
the horizon about the regulatory mechanism of ET-1 gene.
Expression proﬁling analysis can provide important references
and clues for the study of miRNA function. Many miRNAs have
temporal and spatial expression properties. In other words, their
distribution varies with different tissues and organs, and their
expression level varies with different developmental stages of an
organism. The expression proﬁling properties are closely associatedwithmiRNA function. Analysis of the expression proﬁling of miRNA
and prediction of the target gene mRNA have an important antici-
patory value for seeking miRNA target gene. In the present study,
we analyzed the distribution of miRNA-1 and ET-1 mRNA expres-
sion in mouse and part of human tissues and cell lines. We ﬁrst
conﬁrmed that miRNA-1 expression was speciﬁcally expressed in
cardiac and striated muscle tissues, and discovered that there was
a negative correlation on miRNA-1 and ET-1 mRNA expression pro-
ﬁling: miRNA-1 was speciﬁcally and highly expression in the car-
diac and skeletal muscle tissues, and relatively low in the lung
and endothelial cells from the human umbilical vein, which further
suggests that ET-1 may be the target gene of miRNA-1.
Horse serum-induced differentiation of mouse C2C12 myo-
blasts is a classical model for the study of muscle cell differentia-
tion. During C2C12 differentiation, the expression of myogenic
transcription factors such as myogenin increases markedly, and
1020 D. Li et al. / FEBS Letters 586 (2012) 1014–1021closes again after myogenic differentiation [20]. That is the reason
why their expression is low in adult cardiac and skeletal muscles.
We ﬁrst successfully established a C2C12 myoblast model, and
used it to observe changes in myogenin mRNA expression. It was
found that with the progression of myogenic differentiation, miR-
NA-1 expression was up-regulated while ET-1 mRNA expression
was down-regulated gradually, suggesting that miRNA-1 may
down-regulate the level of ET-1 mRNA expression during the pro-
cess of myogenic differentiation, which also provides a new clue
for the study of miRNA-1 and ET-1 functions.
Luciferase reporter gene assay is a common technique used to
preliminarily determine the regulatory effect of miRNAs on target
genes. Our study conﬁrmed that miRNA-1 could inhibit ET-1 30UTR
integrated reporter gene, and found that the regulatory effect of
miRNA-1 on luciferase reporter gene integrated with ET-1 30UTR
(1-404) wt sequence was more obvious than that on full-length
ET-1 30UTR. We presume that the short segment is more beneﬁcial
to the binding of the target gene and miRNA-1, and easier to exer-
cise the regulatory effect than the full-length sequence. The longer
the RNA segment the more complex the secondary structure is,
which may produce some unfavorable effect on the binding of
the target gene and miRNA-1, such as in stereo-hindrance effect.
On the contrary, a small and short segment is beneﬁcial to the
exposure of the target gene, and therefore is easy to bind with miR-
NA to exercise the inhibitory effect.
Based on our understanding about the effect of miRNA-1 on the
function of the non-translated region of ET-1 30UTR, we further
demonstrated in Hela cells that miRNA-1 had an inhibitory effect
on endogenous ET-1 expression. Hela is a tumor cell line originat-
ing from epithelial tissue, and can express a certain amount of
endogenous ET-1 [21]. Hela releases ET-1 by following a certain
time–concentration curve. Hela is also characterized by easy trans-
fection, and tolerance to serum-free culture. In addition, Hela itself
does not express miRNA-1. The amount of miRNA-1 expression in
Hela can be increased markedly by means of an miRNA vector,
which is beneﬁcial to observing the functional effect of miRNA-1
on ET-1. We therefore chose Hela as the cell model for the studying
the regulatory effect of miRNA-1 on the expression of endogenous
ET-1. Mature ET-1 is a secretary small-molecule polypeptide
consisting of 21 amino acid residues. It is usually detected by ELISA
and radioimmunoassay. ET-1 is not a direct translation product of
ET-1 mRNA. ET-1 mRNA ﬁrst translates into ppET-1 (a polypeptide
consisting of 212 amino acids), then forms a big ET consisting of 38
amino acids under the action of endopeptidase and carboxypepti-
dase, and ﬁnally forms mature ET-1 consisting of 21 amino acids
under the action of endothelin converting enzyme-1. In addition,
ET-1 undergoes a series of storage and secretion processes before
releasing out of cells. These factors may explain why the inhibitory
effect of miRNA-1 on the expression of ET-1 protein in Hela cell
supernatant was not so obvious as that detected in the recombi-
nant reporter gene integrated with ET-1 30UTR.
Our future research is planned to clarify physiologic and patho-
logic implications of the inhibitory effect of miRNA-1 on ET-1 gene
expression. The expression and distribution of ET-1 and miRNA-1
in the heart have temporal and spatial properties during the embry-
onic development. Altered spatial expression and distribution in
some pathologic conditions may induce abnormal development of
the heart. Studies have demonstrated that miRNA-1 expression
was down-regulated in the course of myocardial hypertrophy, and
that miRNA-1 had an inhibitory effect on myocardial hypertrophy
[12,22,23]. The effect of ET-l in promoting myocardial hypertrophy
and the important position of endogenous ET-1 of cardiomyocytes
in myocardial hypertrophy have been generally recognized
[24,25].Whether decreased expression ofmiRNA is a factor contrib-
uting to increased expression of endogenous ET-1 in myocardial
hypertrophy? Whether ET-l also induces down-regulation ofmiRNA-1 when it promotes myocardial hypertrophy? The cause-
effect relationship of the two questions warrants further inves-
tigation.
In summary, we preliminarily conﬁrmed that miRNA-1 had an
inhibitory effect on ET-1 expression. This discovery widens our
horizon about the regulatory mechanism of ET-1 gene expression
and lays a foundation for further investigation of the physiologic
and pathologic implications of this regulatory effect.
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